Drug "Lerivon". tilmaamaha ah ee ay la isticmaalo.

"Lerivon" - daroogada la xidhiidha diiqadda. In si ay u noqon in ay bartaan qaabka iyo qaybaha ay had iyo jeer ku lifaaqan daroogada "Lerivon" edbinta awoodaan.

Dhismaha "lerivon" waa walax firfircoon daroogada - hydrochloride mianserin (30 mg), iyo maaddooyinka kaabayaal: milmahayn magnesium, istaarijka baradho, meliltsellyuloza, silica ammooniya kalloidny, phosphate calcium, titanium dioxide (E 171), macrogol, hypromellose.

The mianserin walax firfircoon la xidhiidha a xeryahooda piperazino-azepine kuwaas oo kiimikaad la xiriira daawooyinka murugada tricyclic. "Lerivon" xidhmey receptor alpha2 oo uu hakiyo reuptake of norepinephrine, markaa si ay kordhaan gudbinta noradrenergic maskaxda. Oo weliba waxaannu ku aqoonsaday dhexgalka serotinovymi la receptors in habka dhexe ee neerfayaasha. daroogada ayaa sidoo kale waxay leedahay saameyn anxiolytic, taas oo ah mid aad u muhiim ah in daaweyn jiray jirrada walaaca iyo hurdo xumo, kuwaas oo ay sababtay gobolka guud niyad of nin.

Lifaaqsan daroogada "Lerivon" war muujinaysaa in daawada si fiican loo dulqaatay by bukaanka qaba cudurada nidaamka wadnaha, iyo sidoo kale dadka da'da ah. At qaadasho in daaweeyn waa wax ku ool ah "Lerivon" ayaa gebi ahaanba aan waxtar lahayn oo ku saabsan nidaamka wadnaha. Isagu ma aha hanti waxqabadka anticholinergic. Waxay leedahay saamayn yar cardiotoxic ee xad dhaafka badan murugada tritseklicheskie. "Lerivon" ma tilmaamayso ku Doodeen antihypertensive iyo wakiilada sympathomimetic.

daroogada la isticmaalay "Lerivon 'ee Niyadjabka ee etiologies kala duwan. Si kastaba ha ahaatee, waxaa jira sababo dhowr ah. In si ay u bartaan macaamiisha iyaga la lifaaqan daroogada "Lerivon" edbinta. ku akhri si faahfaahsan, waxaad ka arki kartaa in ay tahay wax aan macquul aheyn in ay aqbalaan "Lerivon": lacala diidmo in walaxda firfircoon - mianserin ama wax qaybaha amarro; carruurta iyo dhallinyarada da'doodu ka yar tahay 18 sano, ee cudurada beerka ku xadgudbay daran ee hawlihiisa.

Taxadarka in ay qaataan kharashka daroogada this loogu talagalay dadka qaba kilyaha ama beerka, wadnaha chronic, gulukooma xagal-xidho, diabetes, hypertrophy Prostatic. Marka la eegayo muddada uurka iyo nuujinta, waxaa ku lifaaqan daroogada "Lerivon" edbinta kuu ogolaanayaa inaad si ay u bartaan macluumaad tijaabo ayaa la kala sameeyey xoolaha iyo soo ururiyey in ixtiraamka qofka, Xogo kooban. Iyadoo ku saleysan, waxaa la ogaaday in mianserin laha neontalnogo ama dhaawac intrauterine. Waxaa sidoo kale laga helay mianserin in nuugo caanaha naaska ku jira xaddi yar. Si kastaba ha ahaatee, inkastoo ay taasi ka hor "Lerivon" marka quudinta ama uurka, waa in aad is barbar faa'iido u ah daroogada la halista ka iman karta in ay ilmaha caloosha iyo ilmaha.

Waxaad ka akhrisan kartaa oo ku saabsan alaabta dib u eegista daawooyinka "Lerivon" inta aan la isticmaalin si toos ah daroogada. Laga soo bilaabo dib u eegista aad mararka qaarkood ka heli kartaa macluumaad waxtar leh. Tusaale ahaan, waxaad ku baran kartaa oo ku saabsan qaar ka mid ah waxyeellooyinka: marar aad u badan somnolence; mararka qaar kor u kacay miisaanka jidhka; ku tilmaamay sida Xaaladu aad dhif u ah Agranulocytosis, horumarinta leukopenia karo, casiraad, arthralgia, gynecomastia, barar, sii daraysa ee beerka.

Lifaaqsan daroogada "Lerivon 'tilmaamaha isticmaalka aan loogu talagalay ujeeddooyin-daweynta is iyo tixraaca oo keliya. Waa lagama maarmaan in taas xisaabta ku darsanaa hor isticmaalka daroogada ah. Daaweynta uu dhakhtarku soo qoro.